Filing Overview
Registrant: Kensington Capital Acquisition Corp. IV. Filing date and event date: September 7, 2022. The Form 8-K reports amendments and developments related to Kensington’s proposed business combination with Amprius Technologies, Inc.
Business Context and Transaction
- Kensington entered into subscription agreements for a private investment in public equity transaction, or PIPE.
- Investors agreed to purchase 1,337,500 PIPE Units at $10.00 per unit, for gross proceeds of approximately $13.4 million.
- Each PIPE Unit consists of one share of post-business-combination New Amprius Common Stock and one warrant to purchase one share.
- PIPE warrants will have a $12.50 exercise price, will not be exchange-listed, and will generally have redemption terms requiring the stock’s average sales price to exceed $20.00 per share.
- The PIPE is contingent on the substantially concurrent closing of the business combination and is intended to provide additional capital, offset potential shareholder redemptions, and potentially satisfy the minimum cash condition.
Financial Metrics, Liquidity, and Capitalization
- The filing does not provide revenue, profit, cash flow, margin, debt, or operating liquidity results for Amprius or Kensington.
- The PIPE is expected to raise approximately $13.4 million before transaction expenses.
- PIPE proceeds may be used to offset redemptions of Kensington Class A ordinary shares and help meet the minimum cash condition.
- PIPE securities will not be subject to the proposed New Amprius bylaws’ lock-up restrictions.
Material Changes and Exchange Ratio
- The parties determined an exchange ratio of approximately 1.45590 as of the anticipated closing date.
- Each outstanding Amprius common share is expected to convert into approximately 1.45590 shares of New Amprius Common Stock, with fractional shares rounded down.
- Outstanding Amprius options are expected to convert based on the exchange ratio, with share amounts rounded down and exercise prices adjusted accordingly.
- The exchange ratio is lower than the assumed ratio presented in the previously filed Proxy Statement/Prospectus.
Guidance, Outlook, and Risks
The filing does not provide operating guidance or a financial forecast. Closing of the business combination and the PIPE remains subject to customary conditions, including required approvals and the absence of events preventing completion.
- Key risks include failure or delay in completing the business combination, regulatory or shareholder approval issues, and higher-than-expected redemption requests.
- Other cited risks include Amprius execution and milestone timing, competition, shortages of production materials, delays in constructing or operating production facilities, changes to government clean-energy or electric-vehicle incentives, and the ability to raise additional equity or equity-linked capital.
- Kensington agreed to file a resale registration statement within 30 days after closing for PIPE shares and shares issuable upon exercise of PIPE warrants, subject to the agreement’s terms.
- Management’s statements regarding the transaction, closing, exchange ratio, and PIPE are forward-looking and may differ materially from actual outcomes.
Investor Verification Checklist
- Verify the final closing date and whether all business-combination conditions were satisfied.
- Confirm the final exchange ratio and resulting share count after rounding, redemptions, and option conversions.
- Confirm whether all 1,337,500 PIPE Units closed and the actual net proceeds received.
- Review the definitive subscription and warrant agreements for investor rights, redemption provisions, and dilution implications.
- Assess the final minimum cash position, remaining liquidity, and any additional financing needs of the combined company.
- Review the Proxy Statement/Prospectus and subsequent SEC filings for updated risks, financial statements, and transaction terms.